- Home
- BTZ vs CRMD Comparison
BTZ vs CRMD Comparison
Compare BTZ & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTZ | CRMD |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 958.1M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | BTZ | CRMD |
|---|---|---|
| Price | $10.59 | $7.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $15.29 |
| AVG Volume (30 Days) | 279.4K | ★ 4.1M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 9.40% | N/A |
| EPS Growth | N/A | N/A |
| EPS | 1.41 | ★ 2.25 |
| Revenue | N/A | ★ $214,303,672.00 |
| Revenue This Year | N/A | $628.67 |
| Revenue Next Year | N/A | $14.64 |
| P/E Ratio | $7.57 | ★ $3.23 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $9.10 | $5.60 |
| 52 Week High | $11.13 | $17.43 |
Technical Indicators
Market Signals| Indicator | BTZ | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 32.93 | 30.29 |
| Support Level | $10.52 | $6.55 |
| Resistance Level | $10.86 | $7.59 |
| Average True Range (ATR) | 0.05 | 0.60 |
| MACD | -0.02 | -0.19 |
| Stochastic Oscillator | 21.03 | 12.11 |
Price Performance
Historical ComparisonAbout BTZ BlackRock Credit Allocation Income Trust
Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.